Global Fertility Supplements Market - Focused Insights 2024-2029

GLOBAL FERTILITY SUPPLEMENTS MARKET INSIGHTS

The global fertility supplements market was valued at USD 2.12 billion in 2023 and is expected to reach USD 3.32 billion by 2029, growing at a CAGR of 7.73% during the forecast period. "The fertility supplements market is primarily driven by rising concerns about infertility, increased focus and expenditure on reproductive healthcare, delayed childbearing, and declining global fertility rates. The growing prevalence of infertility worldwide fuels the demand for fertility care. Millions of couples globally experience infertility, necessitating fertility treatments. Changing lifestyles and delayed pregnancies are key factors driving the need for fertility care and support. Additionally, the increasing prevalence of adolescent pregnancies and concerns regarding advanced maternal age contribute to the demand for fertility solutions. In developing countries, high infertility rates significantly propel market growth. For example, India's rapidly expanding fertility supplement market is driven by a large patient demographic and the presence of numerous market players. Fertility supplements are scientifically validated health solutions recommended by medical professionals to enhance fertility in men and women. These supplements contain vitamins, minerals, antioxidants, and other beneficial ingredients. Plant-derived ingredients have seen a surge in demand recently. In men, these ingredients improve sperm motility, count, and testosterone levels. In women, they elevate estrogen levels and regulate menstrual cycles, ultimately enhancing fertility by supporting reproductive hormone balance and driving market growth.

MARKET TRENDS & DRIVERS

Male Fertility: A Growing Focus in Reproductive Health

The growing awareness of male infertility is a key emerging trend significantly impacting market growth. While female fertility concerns are well-established, male infertility is now receiving heightened attention among the adult male demographic. Globally, there is a rapid decline in sperm count and semen quality attributed to contemporary lifestyles and associated health issues. Unhealthy dietary habits, demanding work environments, environmental pollutants, and the use of alcohol, tobacco, and cigarettes are contributing to the increased incidence of male infertility. Global sperm counts have decreased by approximately 70% in recent years. Male infertility can stem from various factors, including infections, hormonal dysregulation, celiac disease, and genetic predispositions.

Growing R&D on New Fertility Supplements

Fertility supplements are a popular alternative to traditional fertility treatments. However, conflicting claims regarding their benefits and drawbacks, along with the efficacy of associated ingredients, have raised significant concerns in recent years. This has driven increased research into clinically proven fertility supplement ingredients. Currently, several scientifically validated ingredients are gaining popularity, offering revenue growth opportunities for vendors. One such ingredient is Acetyl L-Carnitine, an antioxidant that has been clinically proven to support sperm health and improve sperm motility in males.

High Prevalence and Incidence of Infertility

The global prevalence and incidence of infertility are rising significantly. Approximately 1 in 6 adults (17%) worldwide are affected by infertility, a global health concern impacting an estimated 186 million individuals. According to the WHO, in 2022, 50 million couples globally experienced infertility. This condition severely affects the reproductive systems of both genders, defined as the inability to conceive after 12 months or more of regular, unprotected intercourse. Sub-Saharan Africa, Northern Africa, and Western Asia have witnessed a notable decline in fertility rates. Market growth is challenged by concerns regarding the efficacy, safety, and efficiency of fertility supplements, the availability of alternative fertility solutions, and limited awareness and access to fertility care.

INDUSTRY RESTRAINTS

Challenges in Fertility Health: Awareness and Access Issues

Global infertility care has big differences. Supplements are expensive, people don't know enough, and treatments are unequal. In developing countries, high birth rates mean less awareness. Bad healthcare and low spending make infertility worse. Treatments are too expensive for many. This hurts the supplement market. Spending on fertility is low, and many women lack nutrition. Treatments cost over $7,000 per woman, so 10,000 women need $70 billion.

GLOBAL FERTILITY SUPPLEMENTS MARKET SEGMENTATION INSIGHTS

• By Product Form: The global fertility supplements market, segmented by product form, comprises capsules, tablets, soft gels, powders, and liquids. The capsule segment maintained the largest market share in 2023. This market leadership is largely due to consumer preference for capsules, driven by pill fatigue and ease of consumption, resulting in increased demand. Capsules are also favored by manufacturers for their effectiveness, rapid dissolution, and enhanced delivery outcomes. The ease of filling, ingredient integrity, and safe dosage form provided by capsules further drive segmental growth. Capsules facilitate faster and more efficient delivery of fertility-boosting ingredients, leading manufacturers to shift product forms from tablets to capsules in response to consumer demand.
• By Product Type: The global fertility supplements market, segmented by product type, includes synthetic and blend, and natural categories. The synthetic and blend segment is exhibiting notable growth, with the highest anticipated CAGR during the forecast period. These supplements, incorporating both natural and synthetic ingredients, provide enhanced efficacy and expedited clinical outcomes. Blending ensures consistent ingredient distribution. Blend supplements are available in a range of product forms, including tablets, capsules, powders, and liquids. Synthetic fertility supplements utilize APIs such as zinc, folic acid, vitamins C and B6, myo-inositol, and CoQ10, which are manufactured through industrial chemical synthesis. The availability of these ingredients and their raw materials supports high production rates of synthetic-based supplements, thereby driving significant growth in this segment throughout the forecast period.
• By Gender: The women's segment held a substantial share of the global fertility supplements market in 2023 and is projected to experience the highest CAGR during the forecast period. Women exhibit high awareness of fertility health and allocate significant resources to fertility care. The rising birth rate among women of advanced maternal age is a primary factor contributing to declining fertility. Additionally, hormonal and reproductive system disorders, such as anovulation, endometriosis, implantation failure, and uterine fibroids, further drive the demand for fertility supplements.
• By Purchase Methods: The over-the-counter (OTC) segment holds the largest share of the global fertility supplements market, as categorized by purchase methods. The accessibility of OTC fertility supplements, which do not require a prescription, is a major factor driving segmental growth. The less stringent regulatory oversight from the FDA, due to their classification as supplements rather than medications, supports OTC market dominance. Growing public awareness about fertility care and the convenient availability of OTC supplements in health and wellness stores, pharmacies, and other retail locations contribute to segmental growth. The affordability of OTC fertility supplements compared to prescription alternatives, along with the discreet purchasing experience, appeals to a significant portion of consumers.
• By Distribution Channels: The e-commerce distribution channel is demonstrating significant expansion within the global fertility supplements market, exhibiting the most rapid forecasted CAGR throughout the forecast period. E-commerce platforms, including third-party sites, online pharmacies, and direct vendor websites, are revolutionizing product distribution. The transition from traditional retail to e-commerce is a key driver of revenue growth for both established and emerging market players. These online channels provide consumers with a wide array of brand choices, price transparency, comprehensive product descriptions, and peer reviews, effectively attracting a large consumer demographic to online fertility supplement purchases. The COVID-19 pandemic catalyzed a dramatic increase in online sales of vitamins, minerals, and supplements, including fertility supplements, and this trend is projected to sustain robust market growth.

GEOGRAPHICAL ANALYSIS

Europe dominated the global fertility supplements market share. This market leadership is attributed to the rising prevalence of infertility, delayed marriages, increasing chronic disease rates, and rapid lifestyle changes. The escalating burden of obesity among couples of childbearing age is a significant growth driver in the region. Germany, France, the UK, Italy, and Spain are key revenue contributors to the European market. Furthermore, growing government support and educational programs are fostering demand for reproductive health treatments, accelerating market growth.

COMPETITIVE LANDSCAPE

The global fertility supplements market report provides exclusive data on 34 vendors. This market is highly fragmented, with established corporations holding a dominant position. However, significant growth opportunities exist for new entrants. While major players lead the market, numerous emerging, research-driven, and small companies are introducing innovative products and technologies, including natural and synthetic fertility supplements. Leading companies, such as Coast Science, Exeltis USA, Fairhaven Health, LENUS Pharma GesmbH, and Vitabiotics, hold a substantial share of the global market. These vendors are continuously investing in the development of novel ingredients for fertility supplements and are expected to maintain their market dominance through ongoing advancements in solutions.

Global Fertility Supplements Market News

• Some advanced fertility supplements have been launched in the global market, as mentioned below.
• In 2024, Perelel expanded its fertility support portfolio with new supplements, including Fertility+ Support with antioxidants, following a USD 6 million Series A funding round.
• In 2023, Frida launched Frida Fertility Pre-Conception Female and Pre-Conception Male, two fertility supplements developed by experts to support egg and sperm health.
• In 2022, Pillar Healthcare Limited introduced four Pre-Conceive fertility supplement products designed to enhance both male and female fertility.